Potent antifungal cyclic lipopeptides, burkholdines (Bk), were isolated from a culture of Burkholderia ambifaria 2.2N. Bk-1229 (1) and Bk-1097 (2) are octapeptides comprised of nonproteinogenic amino acids, including -hydroxytyrosine, -hydroxyasparagine, and a new fatty acyl amino acid. 1 and 2 are fungicidal against a panel of fungi with potencies 2-60-fold better than amphotericin B control.
tion of the active principles from B. ambifaria extracts using a panel of fungi including Saccharomyces cereVisiae, Candida albicans, and Aspergillus niger led to the discovery of a complex mixture of lipopeptides, the burkholdines. Here, we report the structure elucidation of Bk-1229 (1) and Bk-1097 (2) , which exhibit potent antifungal activity.
Sequential solvent extraction of spray-dried B. ambifaria 2.2N cells with dichloromethane, 2-propanol, and 2-propanol: H 2 O led to recovery of fractions with increasing antifungal activity. Fractions (250 mg) were further purified on an open C 18 column, followed by reversed-phase HPLC using a T3-Atlantis column (Waters), to yield mixtures of 1 and Bk-1213 (900 µg) and 2 and Bk-1081 (800 µg). 4 , which has been assigned as xylose. Further purification of the mixtures resulted in essentially pure 1 (400 µg) and 2 (300 µg).
Using 1D and 2D NMR methods, 1 and 2 were found to be comprised of eight amino acid residues, which were assigned as Gly, two Ser, two Asn, -hydroxy-Asn, -hydroxy-Tyr, and a new fatty acyl amino acid (FAA; Figure 1 ). These amino acid assignments were fully supported by Supporting Information, Figure 9 ). To the best of our knowledge, this substitution pattern is not found in previously reported fatty acids.
The amino acid sequence of 1 and 2 was established primarily by ROESY and HMBC correlations (Supporting Information, Figures 6 and 7 and Tables 2 and 3 ). ROESY correlations between R protons and neighboring residue NH groups allowed assignment of the order of amino acids (Figure 1 ). The placement of xylose was confirmed by a series of ROESY and HMBC correlations between xylose and the nearby fatty acyl chain (Supporting Information, Figures 6 and 7 and Tables 2  and 3) . MS/MS analysis of 1 was complicated by the presence of xylose, which limited fragmentation. By contrast, 2 provided fragment ions that confirmed the NMR-derived sequence (Supporting Information, Figure 1) .
Preliminary attempts to establish the absolute configuration of 1 and 2 employed hydrolysis followed by derivatization with Marfey's reagent. 6 In comparison to authentic standards, Figures 12 and 13) . To determine the placement of these isomers in 1 and 2, relatively selective cleavage at Asx using formic acid was performed. 7 Authentic standards of L-Asp-L-Ser and D-Asp-L-Ser were synthesized. These standards and the formic acid hydrolysate of 1 were derivatized with 2,4-dinitro-1-fluorobenzene. 8 HPLC of the hydrolysate showed the presence of a peak corresponding to either L-Asp-L-Ser or its enantiomer, while no peak for D-Asp-L-Ser or its enantiomer was seen (Supporting Information, Figure 14) . To discriminate between the L,L and D,D isomers, the hydrolysate and the standards were derivatized with Marfey's reagent. A peak coeluting with the L,L isomer was observed, indicating that the peptide is D-Ser II, D-Asn I, L-Asn II, L-Ser I ( Supporting Information, Figure 15 ).
The activities of 1 and 2 were determined in assays against S. cereVisiae to be 0.4 and 1.6 µg/mL, respectively. These compounds are 16-60-fold more potent than amphotericin control against the same S. cereVisiae strain. 1 and 2 are 2-and 16-fold more potent than amphotericin B against A. niger, respectively, and 2-fold more potent against C. albicans (see Supporting Information).
1 and 2 are similar to xylocandin B1 and C1, respectively, which contain the same amino acid constituents and a modified FAA. 9 However, for xylocandins, the modified FAA differs by hydroxylation pattern, and the amino acid sequence and the placement of xylose in xylocandin B1 were not determined (Figure 2) . Burkholdines are also similar to occidiofungins A and B (3). 10 3 is identical to 1, except that Trp and Lys in 3 replace Ser II and Asn I, respectively. There is also a wholly different FAA in 3 (Supporting Information, Figures 10 and 11) . We propose that 1 and 3 are actually very similar and that the data should be reexamined (Supporting Information, Table 4 and Figures 9-11) . The exact nature of the proposed structure of 3 cannot be elucidated from the previously reported data. The original structure assignment of occidiofungins was complicated by an incomplete data set that was obtained using a mixture of compounds, leading to some ambiguity in the data used to assign the original structure. 10 Burkholdines belong to a family of bioactive, cyclic lipopeptides isolated from -proteobacteria such as Burkholderia and Pseudomonas species. [9] [10] [11] Cells and spray dried material from cultures of B. ambifaria strain 2.2N have shown strong antimicrobial activity against a wide variety of fungal pathogens including Phytophthora infestans, Alternaria solani, Botrytis cinerea, and Mycosphaerella figiensis. 4 As the likely source of activity against these strains, the burkholdines provide lead structures for development of new antifungal agents. 
